Clinical Trial

A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects

Name: A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects — clinical trial record (NCT07594847)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The aim of this trial is to evaluate the effect of a single oral dose of HDM1002 tablets on the QT/QTc interval in healthy subjects.

Trial Details

NCT Number	NCT07594847
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Healthy Adult Subject
Enrollment	72 participants
Start Date	2026-03-07
Primary Completion	2026-09-25 (estimated)
Study Completion	2026-11-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-19